MedMira Inc (MIR) - Product Pipeline Analysis, 2024 Update

Summary

MedMira Inc (MedMira) develops, manufactures and markets rapid diagnostics. It develops rapid diagnostics by Rapid Vertical Flow (RVF) technology. The company offers rapid testing solutions in the areas of HIV, H. pylori, hepatitis, syphilis, RVF toolkits and other infectious and sexually transmitted diseases. MedMira offers an RVF toolkit that facilitates the quality of disease diagnosis and management. The company serves hospitals, point-of-care facilities, laboratories, researchers, biotech companies, governments and public health agencies. MedMira markets its products through a network of distributors and business development partners. The company operates through its subsidiaries in Canada, the US and Switzerland. MedMira is headquartered in Halifax, Nova Scotia, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company MedMira Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


MedMira Inc Company Overview
MedMira Inc Company Snapshot
MedMira Inc Pipeline Products and Ongoing Clinical Trials Overview
MedMira Inc – Pipeline Analysis Overview
MedMira Inc - Key Facts
MedMira Inc - Major Products and Services
MedMira Inc Pipeline Products by Development Stage
MedMira Inc Ongoing Clinical Trials by Trial Status
MedMira Inc Pipeline Products Overview
HH Marker Chronic Disease Monitoring Test - Breast Cancer CA-15-3
HH Marker Chronic Disease Monitoring Test - Breast Cancer CA-15-3 Product Overview
HH Marker Chronic Disease Monitoring Test - Cardiac Multiplex B
HH Marker Chronic Disease Monitoring Test - Cardiac Multiplex B Product Overview
MedDuo Dual HIV Ab/Ag Test
MedDuo Dual HIV Ab/Ag Test Product Overview
MedDuo Dual Total Hepatitis B Screen Test
MedDuo Dual Total Hepatitis B Screen Test Product Overview
Miriad Rapid Vertical Flow Assay Tool Kit - Trichomonas Vaginalis
Miriad Rapid Vertical Flow Assay Tool Kit - Trichomonas Vaginalis Product Overview
Multiplo Rapid HBV/HIV/HCV/TP Assay
Multiplo Rapid HBV/HIV/HCV/TP Assay Product Overview
Reveal HBsAg Rapid Test
Reveal HBsAg Rapid Test Product Overview
Reveal TP
Reveal TP Product Overview
Reveal TP Clinical Trial
Reveal TSH Single Test
Reveal TSH Single Test Product Overview
REVEALCOVID-19 Nab-Y [Nab-Y] Neutralizing Test
REVEALCOVID-19 Nab-Y [Nab-Y] Neutralizing Test Product Overview
REVEALCOVID-19 PLUS Total Antibody Test
REVEALCOVID-19 PLUS Total Antibody Test Product Overview
REVEALCOVID-19 Total Antibody Test
REVEALCOVID-19 Total Antibody Test Product Overview
VYRA CoV-2 Antigen Test
VYRA CoV-2 Antigen Test Product Overview
VYRA CoV2Flu Test
VYRA CoV2Flu Test Product Overview
VYRA TriDemic
VYRA TriDemic Product Overview
MedMira Inc - Key Competitors
MedMira Inc - Key Employees
MedMira Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
MedMira Inc, Recent Developments
Feb 25, 2025: MedMira Announces Exclusive Distribution Agreement with Trimedic for Canada
Jan 21, 2025: MedMira Receives Investigational Testing Authorizations for Multiplo TP/HIV Self-Test and Non-Professional Use Applications
Jan 14, 2025: MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use
Jan 09, 2025: MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
Dec 26, 2024: Health Canada approves MedMira's rapid test for HIV and syphilis
Nov 28, 2024: MedMira Reports FY2024 Fourth Quarter and Year End Financial Results
Mar 13, 2024: MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
Dec 26, 2023: MedMira Receives 510(k) Clearance for Reveal G4 Rapid HIV-1/2 Antibody Test
Feb 20, 2023: Maternova and MedMira enter distribution agreement to market rapid diagnostics for HIV, syphilis and hepatitis
Jan 11, 2023: MedMira receives CE mark for its VYRA CoV2Flu Antigen Test
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
MedMira Inc Pipeline Products and Ongoing Clinical Trials Overview
MedMira Inc Pipeline Products by Equipment Type
MedMira Inc Pipeline Products by Indication
MedMira Inc Ongoing Clinical Trials by Trial Status
MedMira Inc, Key Facts
MedMira Inc, Major Products and Services
MedMira Inc Number of Pipeline Products by Development Stage
MedMira Inc Pipeline Products Summary by Development Stage
MedMira Inc Ongoing Clinical Trials by Trial Status
MedMira Inc Ongoing Clinical Trials Summary
HH Marker Chronic Disease Monitoring Test - Breast Cancer CA-15-3 - Product Status
HH Marker Chronic Disease Monitoring Test - Breast Cancer CA-15-3 - Product Description
HH Marker Chronic Disease Monitoring Test - Cardiac Multiplex B - Product Status
HH Marker Chronic Disease Monitoring Test - Cardiac Multiplex B - Product Description
MedDuo Dual HIV Ab/Ag Test - Product Status
MedDuo Dual HIV Ab/Ag Test - Product Description
MedDuo Dual Total Hepatitis B Screen Test - Product Status
MedDuo Dual Total Hepatitis B Screen Test - Product Description
Miriad Rapid Vertical Flow Assay Tool Kit - Trichomonas Vaginalis - Product Status
Miriad Rapid Vertical Flow Assay Tool Kit - Trichomonas Vaginalis - Product Description
Multiplo Rapid HBV/HIV/HCV/TP Assay - Product Status
Multiplo Rapid HBV/HIV/HCV/TP Assay - Product Description
Reveal HBsAg Rapid Test - Product Status
Reveal HBsAg Rapid Test - Product Description
Reveal TP - Product Status
Reveal TP - Product Description
Reveal TP - Evaluation of the Sensitivity, Specificity, And Utility of the Reveal TP (Syphilis) Antibody POCT to Diagnose Infectious Syphilis in Participants Attending the BCCDC's STI Clinic in Vancouver, BC
Reveal TP - Syphilis and HIV Point of Care Testing (POCT) to Improve Access to Testing Among Inner City, Remote, Rural and Hard to Reach Populations in Saskatchewan
Reveal TSH Single Test - Product Status
Reveal TSH Single Test - Product Description
REVEALCOVID-19 Nab-Y [Nab-Y] Neutralizing Test - Product Status
REVEALCOVID-19 Nab-Y [Nab-Y] Neutralizing Test - Product Description
REVEALCOVID-19 PLUS Total Antibody Test - Product Status
REVEALCOVID-19 PLUS Total Antibody Test - Product Description
REVEALCOVID-19 Total Antibody Test - Product Status
REVEALCOVID-19 Total Antibody Test - Product Description
VYRA CoV-2 Antigen Test - Product Status
VYRA CoV-2 Antigen Test - Product Description
VYRA CoV2Flu Test - Product Status
VYRA CoV2Flu Test - Product Description
VYRA TriDemic - Product Status
VYRA TriDemic - Product Description
MedMira Inc, Key Employees
MedMira Inc, Subsidiaries
Glossary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings